Treatments and Outcomes After Platinum-Based Chemotherapy and Anti–PD-(L)1 in NSCLC

In this retrospective cohort study of patients with advanced or metastatic NSCLC, results underscored a significant need for novel treatments, including immuno-oncology combinations.

Authors

Institutions

Publication Details

Journal
JAMA Network Open
Published
2025-06-17
DOI
https://doi.org/10.1001/jamanetworkopen.2025.14527
Citations
3
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
3.14
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Treatments and Outcomes After Platinum-Based Chemotherapy and Anti–PD-(L)1 in NSCLC

Caitlyn T. Solem, Vamsidhar Velcheti, Julia Moore
3 citations
JAMA Network Open
Cancer Immunotherapy and Biomarkers
3.14
article

Treatments and Outcomes After Platinum-Based Chemotherapy and Anti–PD-(L)1 in NSCLC

Caitlyn T. Solem, Vamsidhar Velcheti, Julia Moore
article en
3 citations

Abstract

In this retrospective cohort study of patients with advanced or metastatic NSCLC, results underscored a significant need for novel treatments, including immuno-oncology combinations.

JAMA Network OpenVol. 8(6)
Jacksonville College (US), NYU Langone Health (US), GlaxoSmithKline (United States) (US), Mayo Clinic in Florida (US), NYU Langone’s Laura and Isaac Perlmutter Cancer Center
Good health and well-being
Openalex Percentile: Top 8%
Cancer Immunotherapy and Biomarkers
3.14
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.